The FDA updated its safety labeling for capecitabine and 5-FU to reflect that patients with certain genetic variants risk ...
uniQure N.V. QURE on Friday announced updated preliminary safety and exploratory efficacy data from 11 patients in its Phase ...
Long-term data on four patients' who had received avigbagene parvec gave the firm confidence to advance a late-stage single-arm trial that can support regulatory approval.
The FDA has updated the safety labeling for the chemotherapeutic agents capecitabine (Xeloda) and fluorouracil (5-FU) to ...
AMT-191 has been granted both Orphan Drug and Fast Track designation by the U.S. Food and Drug Administration.
Complete DPD deficiency markedly impairs 5-FU catabolism, increasing risk of early severe diarrhea, mucositis, neutropenia, ...
"All healthcare providers should be aware of the risks of DPD deficiency," inform patients of toxicity risks, and test patients unless treatment is immediately needed, the agency said.
Analysis from continued follow-up of Phase 1/2 clinical trial data in Hunter syndrome (MPS II) reinforces potential for tividenofusp alfa ...
If you’re considering taking an iron supplement, opt for liquid iron supplements. They are often more pleasant-tasting, easier to absorb and gentle on the body.
Krabbe disease, also called globoid-cell leukodystrophy, is caused by a deficiency of the lysosomal enzyme β-galactosylceramidase (GALC), resulting from pathogenic variants in both copies of the GALC ...
While millions of people over 50 blame their crushing exhaustion on aging or stress, a simple blood test revealed the real culprit behind my afternoon energy crashes—and it wasn't what any of us ...
Doctors have revealed who is most at risk of being vitamin D deficient and the four key symptoms to look out for during the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results